Boston Megan bought BNTC
November 18, 2025 · Form 4 insider transaction
Boston Megan bought 200,000 shares of Benitec Biopharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderBoston Megan
Role—
SecurityOptions (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.